NasdaqGS - Nasdaq Real Time Price USD
MeiraGTx Holdings plc (MGTX)
6.55
+0.06
+(0.92%)
As of 1:31:30 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-104,495
-104,495
-105,365
-73,098
-10,530
Investing Cash Flow
23,479
23,479
34,034
-44,963
-61,717
Financing Cash Flow
54,534
54,534
84,023
95,200
1,708
End Cash Position
105,668
105,668
130,649
115,516
137,703
Interest Paid Supplemental Data
12,029
12,029
13,054
329
139
Capital Expenditure
-4,955
-4,955
-20,174
-44,963
-55,217
Issuance of Capital Stock
59,390
59,390
91,950
25,000
--
Issuance of Debt
--
--
--
75,000
--
Repayment of Debt
--
--
--
--
-1
Free Cash Flow
-109,450
-109,450
-125,539
-118,061
-65,747
12/31/2021 - 6/8/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
DYN Dyne Therapeutics, Inc.
11.12
+3.15%
ATYR aTyr Pharma, Inc.
3.3850
-3.84%
EWTX Edgewise Therapeutics, Inc.
15.01
+1.21%
STOK Stoke Therapeutics, Inc.
9.62
+1.05%
REPL Replimune Group, Inc.
8.82
-0.11%
PTCT PTC Therapeutics, Inc.
49.58
-0.74%
KRYS Krystal Biotech, Inc.
166.89
+0.66%
PRTA Prothena Corporation plc
9.52
-0.73%
RGNX REGENXBIO Inc.
8.97
+1.13%
RCKT Rocket Pharmaceuticals, Inc.
7.32
+2.45%